Tests are lagging and the end of the epidemic is far away – How can it be that nearly four decades after what later became known as HIV was first recognized as a syndrome killing men who had sex with men, and more than a decade since U.S. public health officials recommended routine testing as part of health care for all adults, that nearly 30 percent of men with a male sex partner have never been tested for HIV? Dr. Melanie Thompson, an HIV researcher and physician in Atlanta, among the cities hardest hit by continuing, and avoidable diagnoses of AIDS — advanced HIV — answers that question in this Hill opinion piece. One of the answers — obstacles to routine health services.
Interval since last HIV test . . . Here are the data referred to by Dr. Thompson in the above piece, and they raise questions, including what the leader of global HIV responses might learn from some partners — and is in a disadvantageous position to teach other partners — on confronting barriers between the most vulnerable populations and health services.
How Science Beat Ebola – An investigational vaccination, treatment, and the practice of basic epidemiology, all lacking in the West Africa Ebola epidemic, are making a difference in the control of the current, and according to the World Health Organization, all but controlled Ebola outbreak in the Democratic Republic of Congo, a physician who has confronted both outbreaks writes. But, he notes, until the standard donor white Land Rovers float down rivers, it’s still not over until capacities to put science into practice are shared around the world.
Antimicrobial Resistance – Tackling the Gap in R &D Resources – Why do we have to “pull” as well as “push” for new antibiotic medicines to treat illnesses resistant to the old ones? Because the pharmaceutical industry operates on profit, rather than need, is the conclusion of the World Economic Forum and Wellcome Trust. As we do need new antibiotics, including for tuberculosis, this piece lays out a case for how to get them.